Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng 2
- Development stage
- Unknown
- Lead developer
- Guang'anmen Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Fuzheng 2 is a Traditional Chinese Medicine (TCM) herbal formula developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is primarily investigated for its potential to aid in immune reconstitution among HIV/AIDS patients who are receiving Highly Active Antiretroviral Therapy (HAART). The formula is designed based on the TCM principle of 'Fuzheng,' which focuses on strengthening the body's vital energy (Qi) and immune resistance. In clinical studies, Fuzheng 2 is evaluated for its ability to increase CD4+ T-cell counts and improve immune function in patients who have achieved viral suppression but remain immunological non-responders. It is typically administered as an oral granule or decoction.
- Other names
- Fuzheng 2 formulaFuzheng2 formulaFuzheng-2 formulaFuzheng II recipeFuzheng 2 recipeFuzheng2 recipeFuzheng-2 recipe
02
Targets
CD4 (T lymphocyte surface antigen)
Beyond the preview
Go deeper on Fuzheng 2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fuzheng 2.